Ovarian cancer: no point in lymphadenectomy
Women with advanced ovarian cancer and normal lymph nodes after complete resection experience no survival benefit from systematic removal of pelvic and para-aortic lymphadenaectomy, conclude the authors of a randomised controlled trial.
Median overall survival was 65.5 months with lymphadenectomy versus 69.2 months in women who didn’t undergo the procedure, a difference that was not statistically significant, according to results published in The New England Journal of Medicine.